Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

Georg Lenz, Martin Dreyling, Eva Hoster, +14

Journal of Clinical Oncology

Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer

K. Mross, Lutz Edler, W. Jonat, +3

Annals of Oncology

Breast OncologyOncologyMedicinePhase Ii StudyBreast Cancer +5

Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

E. Heidemann, Herbert Stoeger, Rainer Souchon, +12

Annals of Oncology

Breast OncologyOncologyCombination ChemotherapyHigher QualityMedicine +7

Primary breast cancer therapy in six regions of Germany

Jutta Engel, Gabriele Nagel, Eun‐Kyoung Breuer, +11

European Journal of Cancer

Breast OncologyMedicineCancer ManagementBreast CancerOncology +1

Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).

Hermann Einsele, Peter Liebisch, Christian Langer, +38

Blood

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial

Christian Straka, Peter Liebisch, Hans Salwender, +32

Haematologica

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Stefan Knop, Peter Liebisch, Holger Hebart, +26

Blood

Mitoxantrone in the treatment of relapsed and refractory acute leukemia

Peter Meyer, A. D. Ho, Gerhard Ehninger, +3

Investigational New Drugs

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaMalignant Blood DisorderPharmacology +6

Randomized Clinical Trial Comparing Mitoxantrone with Epirubicin and with Doxorubicin, each Combined with Cyclophosphamide in the First-Line Treatment of Patients with Metastatic Breast Cancer

E. Heidemann, B. Steinke, J. Hartlapp, +7

Oncology Research and Treatment

Mitoxantrone ArmMetastatic Breast CancerOncologyBreast OncologyPharmacology +10

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype

Werner Schroth, Stefan Winter, Florian Büttner, +12

Breast Cancer Research and Treatment

Breast OncologyMedicineHormonal ReceptorGynecologyCancer Genomics +7